Viewing data from:

DESFLURANE

ANDA

DESFLURANE | A208234 | SHANGHAI HENGRUI PHARMACEUTICAL CO LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: SUPRANE(TE code: AN)

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

PIRAMAL CRITICAL CARE INCDESFLURANE USP

DMF 211112007

BLUE ZONE TECHNOLOGIES LTDDESFLURANE USP

DMF 257482012

HEBEI YIPIN PHARMACEUTICAL CO LTDDESFLURANE

DMF 421482025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 5, 2018	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 100%

0 patents0 exclusivities▴

LIQUID;INHALATION | Approved: Feb 26, 2018

No patent or exclusivity listings for this strength.